Efficacy, safety and cost-effectiveness of insulin sensitizers as add-on therapy in metabolic syndrome in patients with secondary sulfonylurea failure: A comparative study.

J Pharmacol Pharmacother · 2010 · PMC3043342 · PMID 21350615

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

Fall in mean FBG, HbA 1C and TGs levels and rise in mean HDL-C level was highly significant ( P < 0.001) with both therapies after the completion of treatment as compared to baseline.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.